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COVID-19 is a rapidly evolving pandemic, which represents a multifaceted global threat.
Given the economic consequences, most researchers agree that social distancing
measures are an effective strategy relative to the cost. Previous studies indicate that
community size as well as viral population risk groups should be considered in forming
an effective targeted social distancing strategy. The resultant delay in the occurrence of
infections in order to support vaccine development has been shown to be an effective
policy. However, a return to normalcy from the current situation would require policy
intervention that transforms the American economy along with continued targeted social
distancing and the use of medical science as a tool to facilitate gradual personal
interactions of low-risk individuals. We believe that the adoption of rapid IgG testing would
be best suitable for widespread population-level screening as part of a comprehensive
plan for incrementally rebuilding the in-person workforce. As such, this crisis represents
an opportunity for the United States to increase automation of the manufacturing sector,
shrink supply chains, and create higher-level jobs in order to reduce the dependency on
other countries for critical supplies. This economic transition to better utilize technology
along with reconstruction of the workforce could improve the standard of living for many
Americans as well as better prepare the US for future pandemics.
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A pandemic represents a multifaceted global threat. In addition to the obvious impact on
population health, pandemics also represent an important threat to the global economy. These
important economic costs can potentially result in a comparable impact on population health, as all
economic factors have a proven positive correlation with key health status outcomes (1). Therefore,
effective public health policy must always respect the impact of economic factors on population
health as health and economic stability remain as variables in a reinforcing feedback loop.

HEALTH AND ECONOMICS
The relationship between economic health and physical health is well–described. Social
determinants of health combines social and economic status based on a combination of race, level
of education, level of income, and community, which defines the characteristics of a person’s life
that drive health related decisions and responses and determines the ability of an individual to
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both move up or down the socioeconomic ladder. These
implications emphasize the importance of the economy in
improving health outcomes through upward social mobility, and
the importance of fair access to economic benefits. Economic
justice was a key issue of debate with the stimulus package that
provided more than $2 trillion dollars in aid for the American
economy. With bipartisan support, the bill eventually passed with
concessions to American families that include direct stimulus
payments and expanded safety net protections including paid
time off, expanded unemployment insurance and debt relief.

severe disease in much younger populations. Also, no proven
medication protocol currently exists, which has resulted in
clinical trials all over the world being conducted to create new
therapies, develop a vaccine, and evaluate existing medications
developed for the treatment of other viral illnesses. With
the latter representing the most immediate benefit with some
data also understood and an existing supply and distribution
chain in place, several of these therapies have been tested in
both laboratory and clinical settings with mixed results. With
remdesivir showing the most promising results so far of existing
antivirals, the US Food and Drug Administration has recently
issued emergency authorization for the experimental use in
treatment of severe COVID-19 (5). This will create a practical
challenge as the demand for the drug will undoubtedly exceed
the existing supply, and the continued interruption of global
supply chains will delay immediate production and distribution
to care centers and patients in need. Despite this, the promise
of remdesivir is encouraging following the disappointing results
from hydroxychloroquine studies, which found unacceptable
side-effects with no significant effect on disease outcome (6, 7).
Still, shortages of hydroxychloroquine were immediate due to
widespread experimental use for both COVID-19 patients as well
as prophylaxis for at risk healthcare workers. These shortages had
important consequences for patients who receive the medication
for the management of chronic autoimmune disorders who were
unable to access their regular treatment. Further, prolonged
mechanical ventilation as the only validated treatment option
in severe COVID19 may likewise present scarcity challenges as
has occurred in Italy and Spain. Furthermore, the reinfection
rate seems to be low, which has important implications for the
evolving immunity of the herd in the future. Existing social
distancing policy in many states has minimized the interaction
of American communities, states and regions that is likely to
support variations in peaks between communities. According
to the Institute for Health Metrics and Evaluation (IHME),
several states with a high volume of cases are expected to have
a prolonged epidemic peak for multiple weeks from early May
to June, with the exception of New York, which attained peak
infections early-mid April. This projection has been calculated
based on the current social distancing measures and the varying
degrees of population density, which will result in outbreaks
in different communities occurring at different times. This has
important implications for the fragile healthcare delivery system
as shifting resources to the areas in the most need of equipment,
medical staff, and other important resources will only be possible
if epidemic peaks do not occur in unison.

Social Distancing Policie
In the absence of proven treatment or vaccination, social
(physical) distancing is the most proven and effective means
of combating communicable infectious diseases. For COVID19 impacted regions worldwide, this remains one of the few
options to slow the spread of the infection while preserving
fragile health delivery institutions. Social distancing policy
usually includes school and business closures and home-based
work recommendations, while enforced curfews and quarantine
orders have also been enacted. Although studies acknowledge
the economic consequences of forced closures of business and
restrictions on private businesses, most researchers agree that
social distancing measures are effective relative to cost as part
of pandemic preparedness (2). Further, the burden of disease
is well-noted to impact the economy without social distancing
policy with many economists arguing that preserving lives has
a shorter term economic impact. However, not all studies agree
on the appropriate iteration of social distancing as clear policy
depends on unique features of the virus as well as geographical
features and risk groups for severe disease and mortality. In a
simulation study of a community of 10,000 residents, targeted
social distancing focusing on children and teenagers was found
effective for the influenza pandemic occurring in the 1950s
through school closures and home-based education. Simulations
similar to the Spanish influenza epidemic identified that more
aggressive targeting was suitable involving children through
young adult populations. These findings indicate that community
size as well as viral population risk groups should be considered
in forming effective targeted social distance policy (3). Because
resource utilization remains a concern for policy makers in the
event of a pandemic, social distancing measures as a method for
reducing the demand for a limited stockpile of antivirals was
not found effective over a long period of time, but delaying the
occurrence of infections in order to support vaccine development
was found to be effective policy (4).

Disease Characteristics and Treatments
DISCUSSION

The implications of the literature applicable to the current
outbreak of the Coronavirus disease 2019 (COVID-19) leave
many questions. Because COVID-19 is caused by a novel
corona virus, many of the disease features researchers anticipated
are vastly different and not well-understood. Among these
features are differing presentations of disease and severity within
populations. While early data suggest that older populations
were at an increased risk for severe disease, the identification of
infections in different populations has revealed the presence of
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The return to normalcy will only occur through a complex
assortment of policy interventions that transform the American
economy, continue targeted social distancing, and use medical
science as a tool to personalize social distancing to facilitate
gradual personal interactions of low risk individuals.
Among the many differences in the COVID-19 pandemic
with previous influenza pandemics, one of the most notable
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is the ability to facilitate operations through technology.
Many industries operating in professional services and
functional departments within companies like management and
administration have already adopted conferencing technology
that facilitate in person interactions. Similar implementations
of technology have not been achieved in manufacturing and
distribution as low level employment has driven these functions
that are now considered essential. Further, the impact of the
global economy most specifically from the burden of disease in
China has placed entire supply chains at risk for critical medical
supplies. The US should use this crisis as an opportunity in invest
in the automation of the manufacturing sector, shrink supply
chains, and create higher level jobs as a benefit to the economy.
Included in this policy should be workforce training available to
those who have been replaced through automation.
Social distancing policies should continue as each region,
state, and city locality make decisions regarding the reopening
of businesses based on their unique disease curve. This has
already happened as a result of unclear federal policy, but the
practice of each community should be standardized. Workplaces
should be adapted to this policy and facilitate standardization of
physical distancing.
Medical science will support the gradual reconstitution of the
in person work force. This step will depend on many factors such
as the development of treatment protocol, vaccine development,
and currently available antibody testing that identifies individuals
with COVID-19 immunity who can re-enter these industries
without posing the risk of infection or infecting others. For
those previously infected with COVID-19 infection, severe acute
respiratory syndrome coronavirus 2 (SARS-CoV2) immunity
develops with an immunoglobulin response measurable by

increasing IgM and IgG levels that have been shown to eliminate
viral load and promote recovery (8). Although antibody testing is
available now, the adoption of rapid IgG testing would be best
suitable for widespread population level screening as part of a
comprehensive plan for incrementally rebuilding the in person
work force.
The human cost of this pandemic is without question
significant. However, the transitioning of the economy to better
utilize technology along with reconstructing the work force could
improve the standard of living for many Americans as well as
better prepare the US for future pandemics. We could also create
a better response annually to seasonal influenza as its annual cost
to the US in terms of morbidity, mortality and loss in quality
adjusted life years is significant. Finally, the political support for
prioritizing public health preparedness as a matter of national
and economic security will likely be stronger and will result in
better surveillance that identifies and prevents future pandemics,
and streamlines strong national and coordinated responses that
will mitigate the potential damage to the economic and health
infrastructure and support a more timely recovery.
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